Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

This study was designed to determine the effect of carotid endarterectomy/angioplasty on early (baseline vs. 3 months) and late (baseline vs. >5 months) cognitive function in patients with asymptomatic lesions.

This systematic research included 31 non-randomized studies.

Regarding the immediate post-operative period, 24 of these papers reported significant improvement in cognitive function; one study reported significant deterioration; three showed mixed results (some scores improved and others worsened), and the rest showed no changes.

In the late post-operative period (that is, well after endarterectomy or angioplasty), one study reported worse cognitive function, another showed significant improvement, some obtained mixed results, and most showed no change from baseline.

These results showed a similar distribution when comparing small studies with larger ones, controlled vs. uncontrolled studies, studies that used endarterectomy vs. others that used angioplasty, and studies with longer or shorter follow-up.


Read also: HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy.


Conclusion

Intervention, whether it be endarterectomy or angioplasty, rarely improves long-term cognitive function (<2%). However, it rarely makes it worse (in fact, magnitude is similar: 2%).

In the long term, the vast majority of papers (69%) could not prove an improvement in cognitive function. Only a few studies indicated improvement. The rest reported no change.

Until we have new papers that better identify the most vulnerable patients (with poor functional reserve) or provide clear evidence that silent embolism from a diseased carotid artery does indeed lead to cognitive impairment, we will remain in a sea of speculation.

Original title: Effect of Carotid Interventions on Cognitive Function in Patients With Asymptomatic Carotid Stenosis: A Systematic Review.

Reference: Stefano Ancetti et al. Eur J Vasc Endovasc Surg. 2021 Aug 30;S1078-5884(21)00604-3. Online ahead of print. doi: 10.1016/j.ejvs.2021.07.012. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...